The latest WHO report determined the increasing diversity within the CoV-2 omicron and its
descendent lineages. Some heavily mutated offshoots of BA. 5 and BA. 2, such as BA. 4.6 …

Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical
complications, with frequent fatal issues, occur in others. Disease severity is associated with …

COVID‐19 is a severe infectious disease caused by a SARS‐CoV‐2 infection. It has caused
a global pandemic and can lead to acute respiratory distress syndrome (ARDS). Beyond the …

Currently, few evidences have shown the possible involvement of autoimmunity in patients
affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether …

Coronavirus disease 2019 (COVID‐19) is often associated with interstitial pneumonia.
However, there is insufficient knowledge on the presence of autoimmune serological …

Objective As COVID-19 is a new emerging disease, the hematological/immunological
changes that develop in the infected patients remain unknown. This study aims to …

Objectives In this study, we investigated whether SARS‐CoV‐2 stimulates autoantibody
production. Methods The study included 91 patients hospitalized due to COVID 19, with no …

Immunopathology may play a significant role in the pathogenesis of Coronavirus-Induced
Disease-19 (COVID-19). Immune-mediated tissue damage could result from development of …

Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in
overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …

Abstract Coronavirus disease 2019 (COVID‐19) is still propagating a year after the start of
the pandemic. Besides the complications patients face during the COVID‐19 disease period …